TICAGRELOR

Clinical Indication

For ischaemic stroke or TIA in patients known or suspected of being poor CYP2C19 metabolisers

Comments

Alternative to clopidogrel for secondary prevention in patients confirmed or suspected to be poor CYP2C19 metabolisers.

Date of classification

October 2026

Red

Medicines which should be prescribed only in a specialist setting usually within a secondary or tertiary care service. NB: Some highly specialised RED medicines e.g. injectable treatments for cancer are not included on the LLR APC website list.